XML 139 R110.htm IDEA: XBRL DOCUMENT
v3.22.1

Related Parties - Restricted Stock Program (Detail) R$ / shares in Units, R$ in Thousands | 12 Months Ended
--- | ---
Dec. 31, 2021 BRL (R$) shares R$ / shares
Disclosure of transactions between related parties [line items] |
Balance of number of shares granted | shares | 4,415,294
Total grant costs, including taxes | R$ 118,364
Accumulated recognized grant costs | (50,603)
Accumulated unrecognized grant costs | R$ 67,761
Restricted Stock Award [Member] | Grant Date, October 1, 2017 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | October 1, 2017
Balance of number of shares granted | shares | 240,000
Vesting period | 2023
Market price of shares on the grant date | R$ / shares | R$ 38.19
Total grant costs, including taxes | R$ 9,293
Accumulated recognized grant costs | (9,293)
Accumulated unrecognized grant costs | R$ 0
Restricted Stock Award [Member] | Grant Date, November 8, 2017 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | November 8, 2017
Balance of number of shares granted | shares | 4,596
Vesting period | 2022
Market price of shares on the grant date | R$ / shares | R$ 38.19
Total grant costs, including taxes | R$ 1,018
Accumulated recognized grant costs | (994)
Accumulated unrecognized grant costs | R$ 24
Restricted Stock Award [Member] | Grant Date, April 4, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 4, 2018
Balance of number of shares granted | shares | 31,220
Vesting period | 2022 to 2023
Market price of shares on the grant date | R$ / shares | R$ 34.35
Total grant costs, including taxes | R$ 3,013
Accumulated recognized grant costs | (2,902)
Accumulated unrecognized grant costs | R$ 111
Restricted Stock Award [Member] | Grant Date, September 19, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 19, 2018
Balance of number of shares granted | shares | 80,000
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 19.58
Total grant costs, including taxes | R$ 1,020
Accumulated recognized grant costs | (1,020)
Accumulated unrecognized grant costs | R$ 0
Restricted Stock Award [Member] | Grant Date, September 24, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 24, 2018
Balance of number of shares granted | shares | 80,000
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 18.4
Total grant costs, including taxes | R$ 3,170
Accumulated recognized grant costs | (1,250)
Accumulated unrecognized grant costs | R$ 1,920
Restricted Stock Award [Member] | Grant Date, April 3, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 3, 2019
Balance of number of shares granted | shares | 176,814
Vesting period | 2022 to 2024
Market price of shares on the grant date | R$ / shares | R$ 23.25
Total grant costs, including taxes | R$ 7,004
Accumulated recognized grant costs | (5,479)
Accumulated unrecognized grant costs | R$ 1,525
Restricted Stock Award [Member] | Grant Date, September 2, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 2, 2019
Balance of number of shares granted | shares | 440,000
Vesting period | 2025
Market price of shares on the grant date | R$ / shares | R$ 16.42
Total grant costs, including taxes | R$ 9,965
Accumulated recognized grant costs | (3,875)
Accumulated unrecognized grant costs | R$ 6,090
Restricted Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Balance of number of shares granted | shares | 290,082
Vesting period | 2023 to 2025
Market price of shares on the grant date | R$ / shares | R$ 12.53
Total grant costs, including taxes | R$ 5,668
Accumulated recognized grant costs | (3,135)
Accumulated unrecognized grant costs | R$ 2,533
Restricted Stock Award [Member] | Grant Date, September 16, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 16, 2020
Balance of number of shares granted | shares | 700,000
Vesting period | 2026
Market price of shares on the grant date | R$ / shares | R$ 23.03
Total grant costs, including taxes | R$ 13,259
Accumulated recognized grant costs | (5,847)
Accumulated unrecognized grant costs | R$ 7,412
Restricted Stock Award [Member] | Grant Date, April 7, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 7, 2021
Balance of number of shares granted | shares | 522,716
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 20.85
Total grant costs, including taxes | R$ 17,985
Accumulated recognized grant costs | (5,141)
Accumulated unrecognized grant costs | R$ 12,844
Restricted Stock Award [Member] | Grant Date, September 22, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | September 22, 2021
Balance of number of shares granted | shares | 1,000,000
Vesting period | 2027
Market price of shares on the grant date | R$ / shares | R$ 14.17
Total grant costs, including taxes | R$ 19,547
Accumulated recognized grant costs | (1,087)
Accumulated unrecognized grant costs | R$ 18,460
Performance Stock Award [Member] | Grant Date, April 4, 2018 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 4, 2018
Balance of number of shares granted | shares | 5,550
Vesting period | 2022 to 2023
Market price of shares on the grant date | R$ / shares | R$ 34.35
Total grant costs, including taxes | R$ 356
Accumulated recognized grant costs | (267)
Accumulated unrecognized grant costs | R$ 89
Performance Stock Award [Member] | Grant Date, April 3, 2019 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 3, 2019
Balance of number of shares granted | shares | 83,412
Vesting period | 2022 to 2024
Market price of shares on the grant date | R$ / shares | R$ 23.25
Total grant costs, including taxes | R$ 3,587
Accumulated recognized grant costs | (2,212)
Accumulated unrecognized grant costs | R$ 1,375
Performance Stock Award [Member] | Grant Date, April 1, 2020 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 1, 2020
Balance of number of shares granted | shares | 238,188
Vesting period | 2023 to 2025
Market price of shares on the grant date | R$ / shares | R$ 12.53
Total grant costs, including taxes | R$ 5,494
Accumulated recognized grant costs | (2,960)
Accumulated unrecognized grant costs | R$ 2,534
Performance Stock Award [Member] | Grant Date, April 7, 2021 [Member] |
Disclosure of transactions between related parties [line items] |
Grant date | April 7, 2021
Balance of number of shares granted | shares | 522,716
Vesting period | 2024
Market price of shares on the grant date | R$ / shares | R$ 20.85
Total grant costs, including taxes | R$ 17,985
Accumulated recognized grant costs | (5,141)
Accumulated unrecognized grant costs | R$ 12,844

X
- Definition The date on which share-based payment arrangements are granted. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph IG23 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_IG23&doctype=Implementation%20Guidance -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DateOfGrantOfSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The description of the vesting requirements for a type of share-based payment arrangement that existed at any time during the period. An entity with substantially similar types of share-based payment arrangements may aggregate this information. [Refer: Share-based payment arrangements [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_DescriptionOfVestingRequirementsForSharebasedPaymentArrangement
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table. + References No definition available. + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesLineItems
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of expense arising from share-based payment transactions in which the goods or services received did not qualify for recognition as assets. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 51 -Subparagraph a -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_51_a&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_ExpenseFromSharebasedPaymentTransactionsInWhichGoodsOrServicesReceivedDidNotQualifyForRecognitionAsAssets
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of other equity instruments (ie other than share options) granted in a share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 47 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_47_b&doctype=Standard -URIDate 2021-03-24 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_NumberOfInstrumentsOtherEquityInstrumentsGranted
Namespace Prefix: | ifrs-full_
Data Type: | xbrli:decimalItemType
Balance Type: | na
Period Type: | duration

X
- Definition The weighted average exercise price of other equity instruments (ie other than share options) granted in a share-based payment arrangement. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2021-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2021-en-r&anchor=para_45&doctype=Standard -URIDate 2021-03-24 + Details
Name: | ifrs-full_WeightedAverageExercisePriceOfOtherEquityInstrumentsGrantedInSharebasedPaymentArrangement2019
Namespace Prefix: | ifrs-full_
Data Type: | num:perShareItemType
Balance Type: | na
Period Type: | duration

X
- Definition The amount of accumulated recognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedRecognizedGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition The amount of accumulated unrecognized grant costs arising from share-based payment transactions. + References No definition available. + Details
Name: | ugp_AccumulatedUnrecognizedGrantCosts
Namespace Prefix: | ugp_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_RestrictedStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateOctober12017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateNovember82017Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril42018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember192018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember242018Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril32019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember22019Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril12020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember162020Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateApril72021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=ugp_GrantDateSeptember222021Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ugp_SharebasedPaymentPlanNameAxis=ugp_PerformanceStockAwardMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |